Amgen (AMGN) EBIT Margin (2009 - 2026)
Amgen (AMGN) reported EBIT Margin of 34.95% for Q2 2026, up 6.02 percentage points from 28.94% a year earlier and up 4.02 percentage points from the prior quarter.
Amgen (AMGN) EBIT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amgen's EBIT Margin came in at 29.99%, up 6.53 percentage points year-over-year; for FY2025, it came in at 24.71%, up 2.99 percentage points from FY2024.
- EBIT Margin has a five-year change of -11.24 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at 21.71% in FY2024 (-6.30 pp), 28.01% in FY2023 (-8.33 pp), 36.34% in FY2022 (+6.94 pp) and 29.40% in FY2021 (-6.54 pp).
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q2 2023.
- Year over year, EBIT Margin has now increased in each of the last seven quarters, with an average year-over-year change of +4.88 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q2 2022 (a gain of 20.31 percentage points); the low point was Q1 2024 (a drop of 18.16 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 30.94% (Q1 2026), 27.57% (Q4 2025) and 26.43% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 2.77% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.95% |
| Mar 31, 2026 | 30.94% |
| Dec 31, 2025 | 27.57% |
| Sep 30, 2025 | 26.43% |
| Jun 30, 2025 | 28.94% |
| Mar 31, 2025 | 14.46% |
| Dec 31, 2024 | 25.43% |
| Sep 30, 2024 | 24.07% |
| Jun 30, 2024 | 22.76% |
| Mar 31, 2024 | 13.31% |
| Dec 31, 2023 | 15.51% |
| Sep 30, 2023 | 29.28% |
| Jun 30, 2023 | 38.42% |
| Mar 31, 2023 | 31.47% |
| Dec 31, 2022 | 32.61% |
| Sep 30, 2022 | 39.99% |
| Jun 30, 2022 | 33.00% |
| Mar 31, 2022 | 40.08% |
| Dec 31, 2021 | 33.65% |
| Sep 30, 2021 | 35.46% |
Amgen EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();